Heterogeneity of Incidence and Outcome of Acute Exacerbation in Idiopathic Interstitial Pneumonia
Overview
Authors
Affiliations
Background And Objective: Acute exacerbations (AEs) of idiopathic pulmonary fibrosis (IPF) and other idiopathic interstitial pneumonia (IIP) have a poor prognosis. This study aims to clarify the incidence and prognosis of AE in IPF and the other IIP.
Methods: A total of 229 patients were enrolled, of whom 92 had IPF and 137 had 'IIP other than IPF' based on the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association (ATS/ERS/JRS/ALAT) 2011 IPF Guidelines. IIP other than IPF included 11 patients with a surgical lung biopsy (SLB) and the remainder without such a biopsy. IIP other than IPF was further classified into IIP with a 'possible usual interstitial pneumonia (UIP)' pattern on HRCT (n = 75) and IIP with 'inconsistent with UIP' pattern (n = 62) based on published guidelines. Predictors of AE and the prognosis after AE were examined in these groups.
Results: The 1-year incidence of AE in IPF, IIP with possible UIP HRCT patterns and IIP with inconsistent with UIP HRCT patterns was 16.5%, 8.9% and 4.0%, respectively. AE occurred significantly more frequently in IPF than in IIP with possible UIP and inconsistent with UIP HRCT patterns after adjustment for BMI, modified Medical Research Council score and %forced vital capacity. Prognosis of AE-IIP with possible UIP HRCT pattern was significantly worse than that of AE-IPF.
Conclusion: Although AE occurred significantly less frequently in IIP with possible UIP and inconsistent with UIP HRCT patterns than in IPF, the prognosis of AE-IIP with possible UIP HRCT patterns might be worse than that of AE-IPF.
Acute exacerbation of progressive pulmonary fibrosis: incidence and outcomes.
Kim M, Yang J, Song J Respir Res. 2024; 25(1):415.
PMID: 39593055 PMC: 11590417. DOI: 10.1186/s12931-024-03048-x.
Fukihara J, Sakamoto K, Ikeyama Y, Furukawa T, Teramachi R, Kataoka K Respir Res. 2024; 25(1):202.
PMID: 38730452 PMC: 11083749. DOI: 10.1186/s12931-024-02828-9.
Baig S, Yoo E Life (Basel). 2024; 14(1).
PMID: 38276285 PMC: 10817308. DOI: 10.3390/life14010156.
Tagami Y, Hara Y, Murohashi K, Nagasawa R, Fujii H, Izawa A Sci Rep. 2023; 13(1):22639.
PMID: 38114539 PMC: 10730846. DOI: 10.1038/s41598-023-49342-4.
Cheng X, Jiang S, Pan B, Xie W, Meng J Lipids Health Dis. 2023; 22(1):201.
PMID: 38001499 PMC: 10668383. DOI: 10.1186/s12944-023-01964-3.